We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Original Investigation | Association of VA Surgeons

Systemic Inflammatory Disease and Its Association With Type II Endoleak and Late Interventions After Endovascular Aneurysm Repair

Sherif Y. Shalaby, MD1,2; Trenton R. Foster, MD1,2; Michael R. Hall, MD1,2; Kirstyn E. Brownson, MD1,2; Penny Vasilas, RN1; Daniel G. Federman, MD3,4; Hamid R. Mojibian, MD5,6; Alan Dardik, MD, PhD1,2
[+] Author Affiliations
1Department of Surgery, VA Connecticut Healthcare System, West Haven
2Department of Surgery, Yale University School of Medicine, New Haven, Connecticut
3Department of Medicine, VA Connecticut Healthcare System, West Haven
4Department of Medicine, Yale University School of Medicine, New Haven, Connecticut
5Department of Radiology, VA Connecticut Healthcare System, West Haven
6Department of Radiology, Yale University School of Medicine, New Haven, Connecticut
JAMA Surg. 2016;151(2):147-153. doi:10.1001/jamasurg.2015.3219.
Text Size: A A A
Published online

Importance  Abdominal aortic aneurysms are associated with chronic inflammation within the aortic wall, and previous studies have suggested that chronic inflammation may be a consequence of a dysregulated and persistent autoimmune response. Persistent aortic remodeling after aneurysm repair could place the patient at risk for endoleak or sac rupture.

Objective  To determine whether patients with systemic inflammatory disease and large aneurysms have persistent aortic remodeling after endovascular aneurysm repair (EVAR).

Design, Setting, and Participants  The records of all patients who underwent EVAR between July 2002 and June 2011 at the Veterans Affairs Connecticut Healthcare System were included in this retrospective review. Patients were considered to have a systemic inflammatory disease when confirmed by a referring specialist. Post-EVAR surveillance was performed by yearly imaging.

Intervention  Endovascular aneurysm repair.

Main Outcomes and Measures  Significant endoleak, defined as endoleak and sac diameter increase of 0.5 cm or greater.

Results  A total of 51 of 79 patients (65%) had a systemic inflammatory disease. These patients had similar comorbid conditions compared with patients without inflammation but significantly greater numbers of major postoperative complications after EVAR (23.5% vs 3.6%; P = .02) and overall postoperative complications after EVAR (27.5% vs 7.1%; P = .03). Patients with a history of systemic inflammatory disease developed more endoleaks (45.1% vs 17.9%; P = .02) and late sac expansion (51.0% vs 21.4%; P = .01) and required more interventions (21.6% vs 3.6%; P = .03) during long-term follow-up. Systemic inflammatory disease was significantly associated with significant endoleak (odds ratio, 5.18; 95% CI, 1.56-17.16; P = .007).

Conclusions and Relevance  Patients with systemic inflammatory disease are at high risk for postoperative complications, type II endoleak, sac expansion, and additional interventions after EVAR. Additional strategies for improving the efficacy of EVAR in these patients may be warranted.

Figures in this Article


Place holder to copy figure label and caption
Survival, Endoleaks, and Sac Shrinkage Over Time

A, Cumulative survival after endovascular aneurysm repair in patients with or without systemic inflammatory disease (log rank, P = .99; Gehan-Breslow-Wilcoxon; P = .86). B, Increased type II endoleaks and late sac expansion in patients with systemic inflammatory disease. Endoleaks: P = .03 (log-rank test) and hazard ratio of 3.179 (95% CI, 1.203-6.210). Late sac expansion: P = .02 (log-rank test) and hazard ratio of 6.087 (95% CI, 1.037-9.380). The slightly reduced numbers of patients at year 0 reflect patients with an endoleak at the completion of the operative procedure who were not included. The solid line indicates sac expansion; dashed line, endoleak. C, Decreased sac shrinkage in patients with systemic inflammatory disease. P < .001 (log-rank test) and hazard ratio of 0.106 (95% CI, 0.032-0.350). D, Sac size shrinkage percentage in patients with and without systemic inflammatory disease at 1 and 5 years after endovascular aneurysm repair. Patients without autoinflammatory disease had significant sac size shrinkage after 5-year follow-up compared with first-year follow-up computed tomographic scan. The error bars indicate SEM.

aP < .05 (Bonferroni post hoc analysis; P < .001).

Graphic Jump Location




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

1 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Collections
PubMed Articles